Wednesday, January 8, 2020

Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall

Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall "We understand from Mylan NV#39;s press release dated January 8, 2020, that Mylan Pharmaceuticals has initiated a voluntary recall of three lots of Nizatidine Capsules, USP (150 mg and 300 mg strengths) due to detected trace amounts of impurity...," Solara Active Pharma Sciences in a filing to BSE.

from Moneycontrol Business News https://ift.tt/36B1RCp
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

ITC, Godfrey Phillips shares crack up to 8% on New Year’s Day. What’s the bad news?

Tobacco stocks like ITC and Godfrey Phillips saw significant drops on Thursday. This follows the finance ministry's notification of an a...